Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a ...

Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /CNW/ - Specific Biologics Inc. ("Specific"), a ...

To use this evidence, investigators typically must grow the larvae until adulthood in a laboratory setting and then identify ...

Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the untreatable, today announced that together with Western ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

Romano-Ward syndrome, the most common congenital long QT disorder, often causes exertion- or stimulus-triggered syncope and ...

The simulator takes into account forecasted demand in each region, transportation costs, and the operational capacity of each warehouse.

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and projected to reach US$ 1,081.9 million ...

Agreement Combines Tenaya’s Expertise in Identification and Validation ofGenetic Heart Disease Targets with Alnylam’s Ability ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...